DELRAY BEACH, Fla., March 13, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the Breath Analyzers Market is projected to grow from about USD 2.95 billion in 2026 to USD 5.63 billion by 2031, at a CAGR of 13.8%.
Browse 250 market data Tables and 50 Figures spread through 300 Pages and in-depth TOC on "Breath Analyzers Market- Global Forecast to 2031"
Breath Analyzers Market Size & Forecast:
Breath Analyzers Market Trends & Insights:
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=57484012
The increasing number of road accidents caused by alcohol consumption is a major factor driving the demand for breath analyzers worldwide. Alcohol-impaired driving significantly increases the risk of fatal crashes, prompting governments and traffic authorities to strengthen monitoring and enforcement mechanisms. Breath analyzers play a critical role in detecting alcohol levels quickly and accurately during roadside inspections, accident investigations, and driver screenings. The rising awareness about the societal and economic burden of alcohol-related accidents has encouraged governments to implement routine sobriety checkpoints and mass alcohol testing programs. Additionally, transport companies and public safety agencies are deploying breath analyzers to ensure drivers operate vehicles responsibly. With road safety becoming a global public health priority, investments in advanced alcohol detection technologies are increasing. As accident-prevention strategies continue to emphasize alcohol monitoring, the widespread adoption of breath analyzers across law enforcement and transportation sectors is expected to expand significantly.
Fuel cells accounted for the largest share of the breath analyzers market in 2025.
Fuel-cell technology demonstrates exceptional selectivity for ethanol, the primary compound measured in breath alcohol testing. Unlike semiconductor sensors that may react with other volatile organic compounds such as acetone or methanol, fuel-cell sensors specifically oxidize ethanol to generate an electrical signal proportional to its concentration. This high selectivity ensures more accurate results even in individuals with medical conditions or environmental exposure to other chemicals. The ability to deliver precise readings without interference enhances trust among regulatory bodies, employers, and healthcare professionals. As a result, fuel-cell breath analyzers are widely preferred in professional and evidential applications.
Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=57484012
Law enforcement agencies accounted for the largest market share in 2025.
Many countries have introduced random breath testing (RBT) programs as a preventive strategy to deter drunk driving. Under these programs, law enforcement officers can stop drivers at random and test their BAC levels with portable breath analyzers. This approach has proven highly effective in reducing alcohol-related road accidents and fatalities. The success of RBT programs has led to their expansion across several regions, requiring law enforcement agencies to procure large numbers of breath-testing devices. Continuous enforcement operations, including roadside checkpoints and highway patrols, require reliable, durable breath analyzers, thereby making law enforcement the largest end-user segment in the global market.
The Asia Pacific is expected to exhibit the highest growth rate in the breath analyzers market during the forecast period.
Increasing alcohol consumption across several Asia Pacific countries has contributed to a growing number of alcohol-related road accidents. Rapid urbanization, rising disposable income, and changing social lifestyles have led to higher alcohol intake, particularly among younger populations. Governments are responding to the rise in drunk driving incidents by implementing stricter monitoring and testing measures. Breath analyzers are increasingly being used by traffic police to detect intoxicated drivers and improve road safety. As authorities intensify roadside testing and law enforcement activities, demand for breath alcohol detection devices is expected to grow significantly across major Asia Pacific countries.
Inquire Before Buying@ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=57484012
Top Companies in Breath Analyzers Market:
The Top Companies in Breath Analyzers Market include Drägerwerk AG & Co. KGaA (Germany), Lifeloc Technologies (US), Alcohol Countermeasure Systems Corporation (ACS) (Canada), Intoximeters, Inc. (US), Alcolizer Pty. Ltd. (Australia), AK GlobalTech (India), Quest Products, Inc. (US), Abbott (US), EnviteC Wismar GmbH (Germany), Andatech Private Limited (Australia), Lion Laboratories (UK), CMI, Inc. (US), Advanced Safety Devices (UK), BACtrack, Inc. (US), Bedfont Scientific Ltd. (UK), PAS Systems International (US), AlcoPro, Inc. (US), Akers Biosciences, Inc. (US), C4 Development Ltd. (UK), Guth Laboratories (US), Canary Health Technologies (Canada), Humors Tech (US), Hound Labs (US), Breathomix (Netherlands), and Owlstone Medical (UK).
Browse Adjacent Markets: Medical Devices Market Research Reports & Consulting
Related Reports:
Hematology Analyzers and Reagents Market - Global Forecast to 2029
Allergy Diagnostics Market - Global Forecast to 2031
Drug Screening Market - Global Forecast to 2030
Clinical Chemistry Analyzers Market - Global Forecast to 2030
Life Science Instrumentation Market - Global Forecast to 2031
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
MarketsandMarkets™ SalesPlay is an AI-driven Revenue Intelligence Co-Pilot designed to help revenue teams prioritize the right accounts, identify critical changes early, and surface opportunities ahead of demand, so pipeline builds naturally and deals close with greater consistency.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/breath-analyzers-market-worth-5-63-billion-by-2031--marketsandmarkets-302713156.html
Lindt & Sprüngli liefert operative Rekordzahlen – und erlebt an der Börse dennoch einen heftigen Rückschlag. Die Partizipationsscheine des Premiumschokoladen-Herstellers brachen am Dienstag im frühen Handel zeitweise bis auf 11'000 Franken ein, ein Minus im Tief von deutlich über 7 Prozent. Auslöser ist nicht das vergangene Geschäftsjahr, in dem Lindt EBIT, Reingewinn und Marge im Rahmen oder leicht über den Konsensschätzungen abgeliefert hat, sondern die spürbar zurückgenommene Wachstumsprognose für das laufende Jahr.
Nach einem preisgetriebenen Umsatzplus und einer EBIT-Marge von rund 16,4 Prozent im Jahr 2025, die damit innerhalb der eigenen Zielspanne lag, stellt der Konzern für 2026 nur noch ein organisches Wachstum von 4 bis 6 Prozent in Aussicht. Zuvor lag der Korridor bei 6 bis 8 Prozent. Bereits für das laufende Jahr hatte Lindt seine „übliche“ Wachstumsbandbreite von 6 bis 8 Prozent im Januar noch bestätigt, nur um sie nun auf 4 bis 6 Prozent zu senken. Begründet wird dies mit geopolitischen Spannungen rund um den Iran-Krieg, höheren Energiepreisen, gedämpfter Konsumstimmung und möglichen Belastungen für den Tourismus – was speziell die Verkäufe an Flughäfen und in touristischen Hotspots treffen könnte.
Ein Teil der Analysten zweifelt jedoch daran, dass geopolitische Risiken die alleinige oder wesentliche Erklärung für die vorsichtigere Tonlage sind. So verweist Bernstein auf den vergleichsweise geringen Anteil des Nahen Ostens am Gesamtumsatz von Lindt von lediglich rund 1 bis 2 Prozent. Für Beobachter wie Vontobel-Analyst Jean-Philippe Bertschy signalisiert die neue Guidance daher vor allem Unsicherheit darüber, ob der Konzern nach einem Jahr, in dem das Wachstum praktisch komplett aus massiven Preiserhöhungen und nicht aus steigenden Volumen kam, die Absatzmengen 2026 tatsächlich wieder erhöhen kann.
Gleichzeitig fährt Lindt die Aktionärsvergütung deutlich hoch. Die Dividende soll für das abgelaufene Jahr stärker als erwartet steigen: Je Namenaktie werden 1'800 Franken in Aussicht gestellt – rund 200 Franken mehr als die Analystenschätzungen. Zudem plant das Unternehmen ein neues Aktienrückkaufprogramm von bis zu 1 Milliarde Franken und erhöht die Dividende beim Partizipationsschein auf 180 Franken. Nach einer rund 19-prozentigen Preiserhöhung im Jahr 2025, die trotz rückläufiger Verkaufsvolumina für ein Umsatzwachstum von 8,2 Prozent auf 5,92 Milliarden Franken sorgte, richtet Lindt damit seine Kapitalallokation stärker auf Ausschüttungen aus. An der Börse überlagern allerdings Zweifel an der künftigen Wachstumsdynamik derzeit den positiven Cashflow-Ausweis – der Bewertungsbonus einer vermeintlich verlässlichen Wachstumsgeschichte steht zur Disposition.
